Suzanne Lentzsch
Physician and researcher specializing in multiple myeloma.
Best podcasts with Suzanne Lentzsch
Ranked by the Snipd community
May 10, 2024 • 27min
iwMyeloma 2024 Session I: approaching bone disease, clinical trial updates & the value of MRD as an endpoint in trials
Experts Ola Landgren, Suzanne Lentzsch, Thomas Martin, and Suzanne Trudel discuss bone disease treatment in myeloma, updates with isatuximab and belantamab mafodotin, and the value of measurable residual disease (MRD) in clinical trials at the iwMyeloma 2024 session. Topics include bisphosphonates, sequencing strategies, drug approval, and the importance of data-sharing in myeloma research.
